jo urn al pr e p roo f igg2b monoclonal (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
jo urn al pr e p roo f igg2b monoclonal
Jo Urn Al Pr E P Roo F Igg2b Monoclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 153 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+igg+isotype+control+antibody/Rat+IgG2B+Isotype+Control/pm41999979-580-0-9
Average 93 stars, based on 153 article reviews
Jo Urn Al Pr E P Roo F Igg2b Monoclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 153 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+igg+isotype+control+antibody/Rat+IgG2B+Isotype+Control/pm41999979-580-0-9
Average 93 stars, based on 153 article reviews
jo urn al pr e p roo f igg2b monoclonal - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Neutralization:Article Title: Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C–C Motif Chemokine Ligand 20 Article Snippet: .. For neutralization of the CCL20 experiment, C57BL/6J mice were intraperitoneally (i.p.) injected with CCL20-neutralizing monoclonal antibody (CCL20 mAb, 100 μg/mouse, R&D Systems, USA), or Injection:Article Title: Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C–C Motif Chemokine Ligand 20 Article Snippet: .. For neutralization of the CCL20 experiment, C57BL/6J mice were intraperitoneally (i.p.) injected with CCL20-neutralizing monoclonal antibody (CCL20 mAb, 100 μg/mouse, R&D Systems, USA), or Article Title: Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses Article Snippet: RM1 prostate cancer cells (0.25 × 10 6 cells) were injected subcutaneously to C57BL6/J male mice (#000664) from The Jackson Laboratory. .. When tumor reached the volume of 300–400 mm 3 , mice received an intraperitoneal injection of 45 μg anti-CCL20-blocking antibody (R&D Systems, clone 114908) or Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment Article Snippet: .. C57BL6/J male mice (#000664) received an intraperitoneal injection of 45μg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Article Snippet: CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or rat IgG isotype control antibody (R&D Systems, clone 43414) 1 day prior to intracardiac injection of RM1-BoM3 PCa bone metastases cells. .. CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Article Title: Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection. Article Snippet: .. Each mouse pup was administered either 15 mg of IFN-l2/3 neutralizing antibody (Monoclonal Rat IgG2B clone 244716, catalog MAB17892; R&D Systems, Minneapolis, MN) or 15 mg of Article Title: Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Article Snippet: RM1 prostate cancer cells (0.25 × 106 cells) were injected subcutaneously to C57BL6/J male mice (#000664) from The Jackson Laboratory. .. When tumor reached the volume of 300–400mm3, mice received an intraperitoneal injection of 45μg anti-CCL20-blocking antibody (R&D Systems, clone 114908) or Control:Article Title: Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C–C Motif Chemokine Ligand 20 Article Snippet: .. For neutralization of the CCL20 experiment, C57BL/6J mice were intraperitoneally (i.p.) injected with CCL20-neutralizing monoclonal antibody (CCL20 mAb, 100 μg/mouse, R&D Systems, USA), or Article Title: Anti-CD3 antibody and molecules comprising the antibody Article Snippet: Human T cell line Jurkat cells (ATCC, No. TIB-152) were adjusted to a concentration of 5×106 cells/mL in an RPMI1640 medium containing FBS and added at a concentration of 100 μL/well to a 96-well plate. .. After removal of the supernatant by centrifugation, the culture supernatant of each anti-human CD3 antibody production-positive hybridoma selected by Cell-ELISA in Example 1)-4 or a Article Title: Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses Article Snippet: RM1 prostate cancer cells (0.25 × 10 6 cells) were injected subcutaneously to C57BL6/J male mice (#000664) from The Jackson Laboratory. .. When tumor reached the volume of 300–400 mm 3 , mice received an intraperitoneal injection of 45 μg anti-CCL20-blocking antibody (R&D Systems, clone 114908) or Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment Article Snippet: .. C57BL6/J male mice (#000664) received an intraperitoneal injection of 45μg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Article Snippet: CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or rat IgG isotype control antibody (R&D Systems, clone 43414) 1 day prior to intracardiac injection of RM1-BoM3 PCa bone metastases cells. .. CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Article Title: Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection. Article Snippet: .. Each mouse pup was administered either 15 mg of IFN-l2/3 neutralizing antibody (Monoclonal Rat IgG2B clone 244716, catalog MAB17892; R&D Systems, Minneapolis, MN) or 15 mg of Article Title: Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Article Snippet: RM1 prostate cancer cells (0.25 × 106 cells) were injected subcutaneously to C57BL6/J male mice (#000664) from The Jackson Laboratory. .. When tumor reached the volume of 300–400mm3, mice received an intraperitoneal injection of 45μg anti-CCL20-blocking antibody (R&D Systems, clone 114908) or Centrifugation:Article Title: Anti-CD3 antibody and molecules comprising the antibody Article Snippet: Human T cell line Jurkat cells (ATCC, No. TIB-152) were adjusted to a concentration of 5×106 cells/mL in an RPMI1640 medium containing FBS and added at a concentration of 100 μL/well to a 96-well plate. .. After removal of the supernatant by centrifugation, the culture supernatant of each anti-human CD3 antibody production-positive hybridoma selected by Cell-ELISA in Example 1)-4 or a Concentration Assay:Article Title: Anti-CD3 antibody and molecules comprising the antibody Article Snippet: Human T cell line Jurkat cells (ATCC, No. TIB-152) were adjusted to a concentration of 5×106 cells/mL in an RPMI1640 medium containing FBS and added at a concentration of 100 μL/well to a 96-well plate. .. After removal of the supernatant by centrifugation, the culture supernatant of each anti-human CD3 antibody production-positive hybridoma selected by Cell-ELISA in Example 1)-4 or a Blocking Assay:Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment Article Snippet: .. C57BL6/J male mice (#000664) received an intraperitoneal injection of 45μg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Article Title: Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Article Snippet: CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or rat IgG isotype control antibody (R&D Systems, clone 43414) 1 day prior to intracardiac injection of RM1-BoM3 PCa bone metastases cells. .. CCL20 blocking antibody treatment C57BL6/J male mice (#000664) received an intraperitoneal injection of 45mg anti-CCL20 blocking antibody (R&D Systems clone 114908) or Infection:Article Title: Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection. Article Snippet: .. Each mouse pup was administered either 15 mg of IFN-l2/3 neutralizing antibody (Monoclonal Rat IgG2B clone 244716, catalog MAB17892; R&D Systems, Minneapolis, MN) or 15 mg of |
